Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Exenatide twice-daily (Byetta): Still FDA-approved but rarely prescribed after the once-weekly Bydureon formulation became available in 2012
, ,
The study found that the peptide improved sexual function in men with spinal cord injury, and that it was safe and well-tolerated
Among New York City boroughs, obesity prevalence is highest in the Bronx (34.5%) and lowest in New York City (Manhattan 17.2%)
Phase 2 results are promising
US$ 27.73
US$ 27.29
US$ 20.71
